Imunon, Inc.·4

Feb 19, 4:17 PM ET

Faller Douglas Vincent 4

4 · Imunon, Inc. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Faller Douglas Vincent
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-18+100,000100,000 total
    Exercise: $0.86Exp: 2035-02-18Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
  • [F2]The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject to the grantee's continued service as an employee through each applicable vesting date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4